Form EFFECT CTI BIOPHARMA CORP
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | January 31, 2018 |
Accession Number: | 0000891293-18-000034 | ||||||
Submission Type: | POS AM | ||||||
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Start of Day Message
- CGTN: China deepens reform and opening up, appeals to global investors
- Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!